DMeOB

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 03:13, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

DMeOB
Space-filling model of the DMeOB
Identifiers
  • 1-(3-methoxyphenyl)-N-[(3-methoxyphenyl)methylideneamino]methanimine
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
ECHA InfoCard100.164.778 Edit this at Wikidata
Chemical and physical data
FormulaC16H16N2O2
Molar mass268.316 g·mol−1
3D model (JSmol)
  • COc2cc(ccc2)C=NN=Cc1cccc(OC)c1
  • InChI=1S/C16H16N2O2/c1-19-15-7-3-5-13(9-15)11-17-18-12-14-6-4-8-16(10-14)20-2/h3-12H,1-2H3/b17-11+,18-12+ ☒N
  • Key:FBNPHFBYHYNMHC-JYFOCSDGSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

DMeOB is a drug used in scientific research which acts as a negative allosteric modulator of the metabotropic glutamate receptor subtype mGluR5.[1]

References

  1. ^ O'Brien JA, Lemaire W, Chen TB, Chang RS, Jacobson MA, Ha SN, Lindsley CW, Schaffhauser HJ, Sur C, Pettibone DJ, Conn PJ, Williams DL (September 2003). "A family of highly selective allosteric modulators of the metabotropic glutamate receptor subtype 5". Molecular Pharmacology. 64 (3): 731–40. doi:10.1124/mol.64.3.731. PMID 12920211.